Sign In
Buy FBIO
$2.61
-0.0400 (-1.51%)
At Close: Jun 03, 2026
Analysts' Top Healthcare Picks: Fortress Biotech (FBIO), Sarepta Therapeutics (SRPT)
11:03am, Monday, 13'th Apr 2020
There's a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Fortress Biotech (FBIO), Sarepta Therapeutics (SRPT) and
Analysts’ Top Healthcare Picks: Fortress Biotech (FBIO), Sarepta Therapeutics (SRPT)
11:03am, Monday, 13'th Apr 2020
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Fortress Biotech (
FBIO
–
Research Report
), Sarepta Therapeutics (
SRPT
–
Research Report
) and HC
Marshall Wace LLP Has $57,000 Stake in Fortress Biotech (NASDAQ:FBIO)
10:30am, Monday, 06'th Apr 2020
Marshall Wace LLP decreased its position in Fortress Biotech (NASDAQ:FBIO) by 51.5% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The f
After $50 Billion of Losses, No One Comes to Save the Mortgage Market
05:12pm, Friday, 03'rd Apr 2020
(Bloomberg) -- The market for mortgage-backed securities was in free fall, with fear running rampant and banks seizing collateral.So Tom Barrack, the chairman of real estate investment trust Colony Ca
SoftBank Rally Continues as Company Reportedly Plans to Sell $14 Billion of Alibaba Stake
05:20pm, Tuesday, 24'th Mar 2020
SoftBank’s single largest asset is its 26% stake in Alibaba. It reportedly intends to sell $14 billion of its shares, a little over 10% of its position.
Alpha Bank A.E. : annual earnings release | MarketScreener
01:15pm, Tuesday, 24'th Mar 2020SoftBank Stock Is Rising on a Plan to Sell Assets, Buy Back Shares and Reduce Debt
03:08pm, Monday, 23'rd Mar 2020
The company will sell up to $41 billion in assets and use the proceeds to buy back up to $18 billion in stock and reduce debt.
Twisting Facts to Capitalize on COVID-19 Tragedy: Fortress v. bioMerieux
09:00pm, Wednesday, 18'th Mar 2020
Some people just hate patents and patent owners, we know that. But when tragedy is used to misinform and to advance an ideological agenda, we should all be able to agree that crosses a line.
B.Riley FBR Reiterates Their Buy Rating on Fortress Biotech (FBIO)
10:52am, Wednesday, 18'th Mar 2020
B.Riley FBR analyst Mayank Mamtani reiterated a Buy rating on Fortress Biotech (FBIO) today and set a price target of $6.00. The company's shares closed
B.Riley FBR Reiterates Their Buy Rating on Fortress Biotech (FBIO)
10:52am, Wednesday, 18'th Mar 2020
B.Riley FBR analyst Mayank Mamtani reiterated a Buy rating on Fortress Biotech (FBIO – Research Report) today and set a
Checkpoint Therapeutics: Beat The System
08:59pm, Friday, 21'st Feb 2020
CKPT expects to submitt a BLA for cosibelimab in 2021. CK-101 data update is expected in early 2020. The possibility of fast approval justifies the decision to
Investor Fortress Raises Buyout Offer for Mt. Gox Creditor Claims by 71% - CoinDesk
12:04pm, Thursday, 20'th Feb 2020
Fortress is now offering creditors a "premium price tier" of $1,300 on every bitcoin held by the defunct exchange's estate.
Home for gamers to open in Melbourne CBD
01:00pm, Monday, 17'th Feb 2020
Entertainment company Fortress is hoping video-gaming can become a successful night out drawcard, just like going to a sports bar, bowling or the movies.
Curtis Glovier, Recent CEO of PENSCO and Former Managing Director at Fortress, Joins Star Mountain as a Senior Advisor
10:10pm, Friday, 14'th Feb 2020
Star Mountain Capital, LLC ("Star Mountain"), a specialized investment manager focused on the large and underserved U.S. lower middle-market (companies that generally have between $10 million and $200
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs Feb. 13.) Anavex Life Sciences Corp (NASDAQ: AVXL
